FDA warns of new fake batch of cancer drug Avastin
by Associated Press Wire
February 06, 2013 11:30 AM | 177 views | 0 0 comments | 1 1 recommendations | email to a friend | print
WASHINGTON (AP) — The Food and Drug Administration is warning doctors about another counterfeit version of the cancer drug Avastin distributed in the U.S., the third case involving the best-selling Roche drug in the past year.

The FDA said in an online post that at least one batch of the drug distributed by a New York distributor does not contain the active ingredient in real Avastin, which is used to treat cancers of the colon, lung, kidney and brain. The drug was distributed by Medical Device King, which also does business as Pharmalogical. The vials are packaged as Altuzan, the Turkish version of Avastin that is not approved for use in the U.S.

The agency warned doctors last April about a similar case of fake Turkish Avastin distributed by a U.K. distributor.

Share This Article |
similar stories

FDA will investigate added caffeine in foods | 23 days ago by Mary Clare Jalonick, Associated Press

Idaho spud giant bets on biotech potatoes | 8 days ago by John Miller, Associated Press

FDA lowers age for buyers of Plan B pill to 15 | 21 days ago by Lauran Neergaard, AP Medical Writer

Two new K-9s added to Cherokee Sheriff’s unit | 19 days ago

Cancer Society hits 100 as US cancer rate falls | 17 hrs ago by Mike Stobbe, AP Medical Writer

Comments
(0)
Comments-icon Post a Comment
No Comments Yet
*We welcome your comments on the stories and issues of the day and seek to provide a forum for the community to voice opinions. All comments are subject to moderator approval before being made visible on the website but are not edited. The use of profanity, obscene and vulgar language, hate speech, and racial slurs is strictly prohibited. Advertisements, promotions, spam, and links to outside websites will also be rejected. Please read our terms of service for full guides